Prostate Cancer: Advancing Diagnosis, Treatment, Equity
*Corresponding Author: Nora Hadad, Israel Medical Research Center, Israel, Email: nhadad@israelmedical.orgReceived Date: Sep 01, 2025 / Accepted Date: Sep 29, 2025 / Published Date: Sep 29, 2025
Citation: Hadad N (2025) Prostate Cancer: Advancing Diagnosis, Treatment, Equity. jcd 09: 313.DOI: 10.4172/2476-2253.1000313
Copyright: © 2025 Nora Hadad This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use,distribution and reproduction in any medium, provided the original author and source are credited.
Abstract
Prostate cancer management is advancing with improved screening, personalized genetic profiling, and novel imaging like PSMA PET. Targeted therapies, including PARP inhibitors, are extending survival for advanced disease, while active surveillance is effective for low-risk cases. Artificial Intelligence enhances diagnostics, and survivorship care addresses long-term side effects. Significant racial disparities persist, underscoring the need for equitable care, and dietary patterns influence risk. These multifaceted advancements aim to optimize patient outcomes across the disease spectrum.
